Volume 74 Issue 8 2022 - (April 2022)

• Original Article

  Guillain-Barré syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria

  Síndrome de Guillain-Barré en México: características clínicas y validación de los criterios de Brighton

  J C López-Hernández, J A Galnares-Olalde, A Gutiérrez, S A Estrada, ... E S Vargas-Cañas

  Rev Neurol 2022, 74(8), 258–264

  https://doi.org/10.33588/rn.7408.2021437
• Review

  Pharmacological approach to neuropathic pain: past, present and future

  Abordaje farmacológico del dolor neuropático: pasado, presente y futuro

  A Alcántara-Montero, S R Pacheco-de Vasconcelos

  Rev Neurol 2022, 74(8), 269–279

  https://doi.org/10.33588/rn.7408.2021381
• Original Article

  Models of public care for the population with acquired brain injury in Spain: a study of the situation by Spanish autonomous communities

  Modelos de atención pública a la población con daño cerebral adquirido en España: un estudio de la situación por comunidades autónomas

  M Fernández-Sánchez, A Aza-Hernández, M A Verdugo-Alonso

  Rev Neurol 2022, 74(8), 245–257

  https://doi.org/10.33588/rn.7408.2021372
• Short Report

  Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis

  Efectividad clínica y radiológica del intervalo extendido de dosis con natalizumab en pacientes con esclerosis múltiple recurrente

  D A García-Estévez, G Pérez-Lorenzo, M J Fernández-Pérez, C Cid-Rodríguez, G Ozaita-Arteche

  Rev Neurol 2022, 74(8), 265–268

  https://doi.org/10.33588/rn.7408.2021311
• Case Report

  COVID-19 and herpesvirus encephalitis

  COVID-19 y encefalitis por herpesvirus

  M Ramírez-Colombres, C E Maenza, N S Rocchetti, S P Gattino, ... D H Bagilet

  Rev Neurol 2022, 74(8), 280–283

  https://doi.org/10.33588/rn.7408.2021121